Literature DB >> 2581249

Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates.

S M Schuetze, S Vicini, Z W Hall.   

Abstract

We have examined the physiological effects of antibodies from a highly specific myasthenic serum on acetylcholine receptors at developing rat endplates. The antibodies reduced the amplitude of miniature endplate potentials by 60% in 3- to 6-day-old animals but had no effect after day 14. Between days 7 and 12 the antibodies had an intermediate effect. This is the same period during which acetylcholine receptors with long channel open times (slow channels) disappear and receptors with short open times (fast channels) increase in number. Therefore, we examined the effect of the antibodies at endplates with a mixture of channel types more carefully. At all times tested, both noise analysis and analysis of miniature endplate currents showed that the antibodies reduced slow channel activity selectively. Single-channel recordings indicated that acetylcholine receptors that remained active after antibody treatment had normal gating properties. Thus, the antibodies appeared to silence slow channels selectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581249      PMCID: PMC397593          DOI: 10.1073/pnas.82.8.2533

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.

Authors:  E X Albuquerque; J E Rash; R F Mayer; J R Satterfield
Journal:  Exp Neurol       Date:  1976-06       Impact factor: 5.330

2.  Channel open time and metabolic stability of synaptic and extrasynaptic acetylcholine receptors on cultured chick myotubes.

Authors:  S M Schuetze; E F Frank; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 3.  Control of acetylcholine receptors in skeletal muscle.

Authors:  D M Fambrough
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

4.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

5.  The acetylcholine channel open time in chick muscle is not decreased following innervation.

Authors:  S M Schuetze
Journal:  J Physiol       Date:  1980-06       Impact factor: 5.182

6.  Change in synaptic channel gating during neuromuscular development.

Authors:  B Sakmann; H R Brenner
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

7.  End-plate currents and acetylcholine noise at normal and myasthenic human end-plates.

Authors:  S G Cull-Candy; R Miledi; A Trautmann
Journal:  J Physiol       Date:  1979-02       Impact factor: 5.182

8.  Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors.

Authors:  C B Weinberg; Z W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

9.  Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction.

Authors:  C R Anderson; C F Stevens
Journal:  J Physiol       Date:  1973-12       Impact factor: 5.182

10.  Early events in neuromuscular junction formation in vitro: induction of acetylcholine receptor clusters in the postsynaptic membrane and morphology of newly formed synapses.

Authors:  E Frank; G D Fischbach
Journal:  J Cell Biol       Date:  1979-10       Impact factor: 10.539

View more
  9 in total

1.  Detection of antibodies directed against the cytoplasmic region of the human acetylcholine receptor in sera from myasthenia gravis patients.

Authors:  S J Tzartos; M Remoundos
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Heterogeneous kinetic properties of acetylcholine receptor channels in Xenopus myocytes.

Authors:  A Auerbach; C J Lingle
Journal:  J Physiol       Date:  1986-09       Impact factor: 5.182

3.  Apparent acetylcholine receptor channel conversion at individual rat soleus end-plates in vitro.

Authors:  S M Schuetze; S Vicini
Journal:  J Physiol       Date:  1986-06       Impact factor: 5.182

Review 4.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 5.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

6.  Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates.

Authors:  J O Dolly; M Gwilt; G Lacey; J Newsom-Davis; A Vincent; P Whiting; D W Wray
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

7.  Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate.

Authors:  R A Maselli; D J Nelson; D P Richman
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

8.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor.

Authors:  M P Protti; A A Manfredi; X D Wu; L Moiola; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.